Arthur Mark RICHARDS

Honorary Joint Professor

+65 6601 1036


Honorary Joint Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, NUS.
Director, Cardiovascular Research Institute, NUHS.
Professor in Medicine and Director, Cardiovascular Research Institute, National University of Singapore.
Professor in Medicine and Director, Christchurch, Cardioendocrine Research Group; National Heart Foundation Chair of Cardiovascular Studies, University of Otago, New Zealand.

Research Interest

Cardiologist with interests in Heart failure, acute coronary syndromes and coronary intervention, and hypertension.

Selected Publications

  1. RICHARDS AM, NICHOLLS MG, IKRAM H, WEBSTER MWI, YANDLE TG, ESPINER EA. Renal, haemodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1985; i:545-9.

  2. RICHARDS AM, CLELAND JGF, TONOLO G, McINTYRE GD, LECKIE BJ, DARGIE HJ, BALL SG, ROBERTSON JIS. Plasma alpha natriuretic peptide in cardiac impairment. BMJ 1986; 293:409-12.

  3. DAVIS M, ESPINER E, RICHARDS G, BILLINGS J, TOWN I, NEILL A, DRENNAN C, RICHARDS M, TURNER J, YANDLE T. Plasma brain natriuretic peptide in the assessment of acute dyspnoea. Lancet 1994; 343:440-444.

  4. RICHARDS AM, NICHOLLS MG, YANDLE TG, FRAMPTON C, ESPINER EA, TURNER JG, BUTTIMORE RC, LAINCHBURY JG, ELLIOTT JM, IKRAM H, CROZIER IG, SMYTH DW. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-1929

  5. TROUGHTON RW, FRAMPTON CM, YANDLE TG, ESPINER EA, NICHOLLS MG, RICHARDS AM. Treatment of HF guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-1130.

  6. A. MARK RICHARDS, M. GARY NICHOLLS, ERIC A. ESPINER,JOHN G. LAINCHBURY, RICHARD W. TROUGHTON, JOHN ELLIOTT, CHRISTOPHER FRAMPTON, JOHN TURNER, IAN G. CROZIER, TIMOTHY G. YANDLE. B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction . Circulation 2003;107:2786-2792

  7. JOHN G. LAINCHBURY, ELIZABETH CAMPBELL, CHRISTOPHER M. FRAMPTON, TIMOTHY G. YANDLE, M. GARY NICHOLLS AND A. MARK RICHARDS. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. Journal of the American College of Cardiology 2003; 43: 728-735

  8. P. J. HUNT, A. M. RICHARDS, M. G. NICHOLLS, T. G. YANDLE, R. N. DOUGHTY, E. A. ESPINER. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clinical Endocrinology 1997; 47: 287-296

  9. A. MARK RICHARDS, A, ROBERT DOUGHTY, M. GARY NICHOLLS, STEPHEN MACMAHON, NORMAN SHARPE, JUDY MURPHY, ERIC A. ESPINER, CHRISTOPHER FRAMPTON, TIMOTHY G. YANDLE. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Journal of the American College of Cardiology 2001; 37: 1781-1787.

  10. SJ HOLMES, EA ESPINER, AM RICHARDS, TG YANDLE AND C FRAMPTON. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. Journal of Clinical Endocrinology & Metabolism, 1993; l 76: 91-96